Background: Non-insulin-dependent diabetes mellitus (NIDDM) is associated with an increased incidence of cognitive impairment. Methods: A retrospective chart review study involving 707 patients admitted for rehabilitation after an ischemic stroke. Cognitive status was assessed by the Mini-Mental State Examination (MMSE), and scores lower than 24 points were considered suggestive of cognitive impairment. Results: Age, gender, NIDDM, dementia, and previous stroke emerged as the only statistically significant parameters differing between those with MMSE score lower than 24 or higher. After adjusting for confounding variables, NIDDM (odds ratio 1.46, 95% CI 1.05-2.05, P = .02) was associated with an increased risk of cognitive impairment. Conclusions: Our findings suggest that NIDDM is independently associated with lower MMSE scores in ischemic stroke patients. It identifies individuals in need of specifically targeted interventions and may assist in selecting and developing resources for cognitively impaired diabetic patients.
Wild S., Roglic G., Green A., Sicree R., King H.Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(10):1047-1053.
2.
Centers for Disease Control and Prevention (CDC).Prevalence of diabetes and impaired fasting glucose in adults United States, 1999-2000. MMWR Morb Mortal Wkly Rep. 2003;52(35):833-837.
3.
Gregg EW, Yaffe K., Cauley JA, et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group . Arch Intern Med. 2000;160(2):174-180.
4.
Logroscino G. , Kang JH, Grodstein F.Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years. BMJ. 2004 ;328(7439):548-503.
5.
Ott A., Stolk RP, van Harskamp F., Pols HA, Hofman A., Breteler MMDiabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology. 1999;53(9):1937-1942.
6.
Peila R., Rodriguez BL, Launer LJHonolulu-Asia Aging Study. et al. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes . 2002;51(4):1256-1262.
7.
Yaffe K., Blackwell T., Kanaya AM, Davidowitz N., Barrett-Connor E., Krueger K.Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology. 2004;63(4):658-663.
8.
Gorelick PBRisk factors for vascular dementia and Alzheimer disease. Stroke. 2004;35(11 suppl 1):2620-2622.
9.
Langa KM, Foster NL, Larson EBMixed dementia: emerging concepts and therapeutic implications. JAMA. 2004;292(23): 2901-2908.
10.
Okereke OI, Kang JH, Cook NR, et al. Type 2 diabetes mellitus and cognitive decline in two large cohorts of community-dwelling older adults. J Am Geriatr Soc . 2008;56(6):1028-1036.
11.
Legato MJ, Gelzer A., Goland R., et al. Gender-specific care of the patient withdiabetes: review and recommendations. Gend Med. 2006;3(2):131-158.
12.
Farris W., Mansourian S., Chang Y., et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA. 2003;100(7):4162-4167.
13.
Watson GS, Peskind ER, Asthana S., et al. Insulin increases CSF Abeta42 levels in normal older adults . Neurology. 2003;60(12): 1899-1903.
14.
Hardy J., Selkoe DJThe amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002 ;297(5580):353-356.
15.
Xu W., Qiu C., Gatz M., Pedersen NL, Johansson B., Fratiglioni L.Mid- and late-life diabetes in relation to the risk of dementia. A population-based twin study. Diabetes. 2009;58(1):71-77.
16.
Pohjasvaara T., Erkinjuntti T., Vataja R., Kaste M.Dementia three months after stroke: baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke. 1997;28(4):785-792.
17.
Lobo A., Launer LJ, Fratiglioni L., et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population- based cohorts. Neurology. 2000;54(11 suppl 5):S4-S9.
18.
Rockwood K., Wenzel C., Hachinski V., Hogan DB, MacKnight C., McDowell I.Prevalence and outcomes of vascular cognitive impairment. Neurology. 2000;54(2):447-451.
19.
Kivpelto M., Ngandu T., Laatikainen T., Winblad B., Soininen H., Tuomilehto J.Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol . 2006;5(9):735-741.
20.
Hachinski V.Preventable senility: a call for action against the vascular dementias. J Am Geriatr Soc. 1992;340(8820):645-648.
Folstein M. , Folstein S., McHugh PRMini-Mental State Examination. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
23.
Tombaugh TN , McIntyre NJThe mini-mental state examination: a comprehensive review. J Amer Geriatr Soc. 1992;40(9):922-935.
24.
Wu JH, Haan MN, Liang J., Ghosh D., Gonzalez HM, Herman WHImpact of diabetes on cognitive function among older Latinos: a population-based cohort study. J Clin Epidemiol. 2003;56(7): 686-693.
25.
Hassing LB, Hofer SM, Nilsson SE, et al. Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing. 2004;33(4): 355-361.
26.
Logroscino G., Kang JH, Grodstein F.Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years. BMJ. 2004 ;328(7439):548-553.
27.
Gregg EW, Yaffe K., Cauley JA, et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group . Arch Intern Med. 2000;160(2):174-180.
28.
Fontbonne A. , Berr C., Ducimetiere P., Alperovitch A.Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care. 2001;24(2):366-370.
29.
Kanaya AM, Barrett-Connor E., Gildengorin G., Yaffe K.Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med. 2004;164(12):1327-1333.
30.
Knopman D., Boland LL, Mosley T., et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology. 2001;56(1):42-48.
31.
Rodríguez-Saldana J., Morley JE, Reynoso MT, et al. Diabetes mellitus in a subgroup of older Mexicans: prevalence, association with cardiovascular risk factors, functional and cognitive impairment, and mortality. J Am Geriatr Soc. 2002;50(1): 111-116.
32.
Pohjasvaara T., Erkinjuntti T., Vataja R., Kaste M.Dementia three months after stroke: baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke. 1997;28(4):785-792.
33.
Legato MJ, Gelzer A., Goland R., et al. Gender-specific care of the patient with diabetes: Review and recommendations. Gend Med. 2006;3(2):131-158.
34.
Hardy J., Selkoe DJThe amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002 ;297(5580):353-356.
